Top

Published in:

Open Access 01-08-2012 | Review

MRI of the lung (3/3)—current applications and future perspectives

Authors: Jürgen Biederer, S. Mirsadraee, M. Beer, F. Molinari, C. Hintze, G. Bauman, M. Both, E. J. R. Van Beek, J. Wild, M. Puderbach

Published in: Insights into Imaging | Issue 4/2012

Abstract

Background

MRI of the lung is recommended in a number of clinical indications. Having a non-radiation alternative is particularly attractive in children and young subjects, or pregnant women.

Methods

Provided there is sufficient expertise, magnetic resonance imaging (MRI) may be considered as the preferential modality in specific clinical conditions such as cystic fibrosis and acute pulmonary embolism, since additional functional information on respiratory mechanics and regional lung perfusion is provided. In other cases, such as tumours and pneumonia in children, lung MRI may be considered an alternative or adjunct to other modalities with at least similar diagnostic value.

Results

In interstitial lung disease, the clinical utility of MRI remains to be proven, but it could provide additional information that will be beneficial in research, or at some stage in clinical practice. Customised protocols for chest imaging combine fast breath-hold acquisitions from a “buffet” of sequences. Having introduced details of imaging protocols in previous articles, the aim of this manuscript is to discuss the advantages and limitations of lung MRI in current clinical practice.

Conclusion

New developments and future perspectives such as motion-compensated imaging with self-navigated sequences or fast Fourier decomposition MRI for non-contrast enhanced ventilation- and perfusion-weighted imaging of the lung are discussed.

Main Messages

• MRI evolves as a third lung imaging modality, combining morphological and functional information.

• It may be considered first choice in cystic fibrosis and pulmonary embolism of young and pregnant patients.

• In other cases (tumours, pneumonia in children), it is an alternative or adjunct to X-ray and CT.

• In interstitial lung disease, it serves for research, but the clinical value remains to be proven.

• New users are advised to make themselves familiar with the particular advantages and limitations.

Puderbach M, Hintze C, Ley S, Eichinger M, Kauczor H-U, Biederer J (2007) MR imaging of the chest: a practical approach at 1.5T. Eur J Radiol 64:345–355PubMedCrossRef

Biederer J, Hintze C, Fabel M, Jakob PM, Horger W, Graessner J, Bolster BD, Heller M (2011) MRI of the lung—ready…get set…go! Magnetom Flash 46:6–15

Biederer J, Both M, Graessner J, Liess C, Jakob P, Reuter M, Heller M (2003) Lung morphology: fast MR imaging assessment with a volumetric interpolated breath-hold technique: initial experience with patients. Radiology 226:242–249PubMedCrossRef

Biederer J, Reuter M, Both M, Muhle C, Grimm J, Graessner J, Heller M (2002) Analysis of artefacts and detail resolution of lung MRI with breath-hold T1-weighted gradient-echo and T2-weighted fast spin-echo sequences with respiratory triggering. Eur Radiol 12:378–384PubMedCrossRef

Biederer J, Hintze C, Fabel M (2008) MRI of pulmonary nodules: technique and diagnostic value. Cancer Imaging 8:125–130PubMedPubMedCentralCrossRef

Biederer J, Schoene A, Freitag S, Reuter M, Heller M (2003) Simulated pulmonary nodules implanted in a dedicated porcine chest phantom: sensitivity of MR imaging for detection. Radiology 227:475–483PubMedCrossRef

Biederer J, Busse I, Grimm J, Reuter M, Muhle C, Freitag S, Heller M (2002) Sensitivity of MRI in detecting alveolar Infiltrates: experimental studies. Rofo 174:1033–1039PubMedCrossRef

Hintze C, Dinkel J, Biederer J, Heussel CP, Puderbach M (2010) New procedures. Comprehensive staging of lung cancer by MRI. Radiologe 50:699–705PubMedCrossRef

Biederer J, Bauman G, Hintze C, Fabel M, Both M (2011) Magnetresonanztomographie. Der Pneumologe 8:234–242CrossRef

10.

Stern M, Wiedemann B, Wenzlaff P (2008) From registry to quality management: the German Cystic Fibrosis Quality Assessment project 1995 2006. Eur Respir J 31:29–35PubMedCrossRef

11.

Gibson RL, Burns JL, Ramsey BW (2003) Pathophysiology and management of pulmonary infections in cystic fibrosis. Am J Respir Crit Care Med 168:918–951PubMedCrossRef

12.

de Jong PA, Mayo JR, Golmohammadi K, Nakano Y, Lequin MH, Tiddens HAWM, Aldrich J, Coxson HO, Sin DD (2006) Estimation of cancer mortality associated with repetitive computed tomography scanning. Am J Respir Crit Care Med 173:199–203PubMedCrossRef

13.

Puderbach M, Eichinger M, Gahr J, Ley S, Tuengerthal S, Schmähl A, Fink C, Plathow C, Wiebel M, Müller FM, Kauczor HU (2007) Proton MRI appearance of cystic fibrosis: comparison to CT. Eur Radiol 17:716–724PubMedCrossRef

14.

Puderbach M, Eichinger M, Haeselbarth J, Ley S, Kopp-Schneider A, Tuengerthal S, Schmaehl A, Fink C, Plathow C, Müller FM, Kauczor HU (2007) Assessment of morphological MRI for pulmonary changes in cystic fibrosis (CF) patients: comparison to thin-section CT and chest x-ray. Invest Radiol 42:715–725PubMedCrossRef

15.

Failo R, Wielopolski PA, Tiddens HAWM, Hop WCJ, Mucelli RP, Lequin MH (2009) Lung morphology assessment using MRI: a robust ultra-short TR/TE 2D steady state free precession sequence used in cystic fibrosis patients. Magn Reson Med 61:299–306PubMedCrossRef

16.

Eichinger M, Puderbach M, Fink C, Gahr J, Ley S, Plathow C, Tuengerthal S, Zuna I, Müller F-M, Müller FM, Kauczor HU (2006) Contrast-enhanced 3D MRI of lung perfusion in children with cystic fibrosis–initial results. Eur Radiol 16:2147–2152PubMedCrossRef

17.

Eibel R, Herzog P, Dietrich O, Rieger CT, Ostermann H, Reiser MF, Schoenberg SO (2006) Pulmonary abnormalities in immunocompromised patients: comparative detection with parallel acquisition MR imaging and thin-section helical CT. Radiology 241:880–891PubMedCrossRef

18.

Rupprecht T, Böwing B, Kuth R, Deimling M, Rascher W, Wagner M (2002) Steady-state free precession projection MRI as a potential alternative to the conventional chest X-ray in pediatric patients with suspected pneumonia. Eur Radiol 12:2752–2756PubMedCrossRef

19.

Hatabu H, Gaa J, Kim D, Li W, Prasad PV, Edelman RR (1996) Pulmonary perfusion: qualitative assessment with dynamic contrast-enhanced MRI using ultra-short TE and inversion recovery turbo FLASH. Magn Reson Med 36:503–508PubMedCrossRef

20.

Theilmann RJ, Arai TJ, Samiee A, Dubowitz DJ, Hopkins SR, Buxton RB, Prisk GK (2009) Quantitative MRI measurement of lung density must account for the change in T(2) (*) with lung inflation. J Magn Reson Imaging 30:527–534PubMedPubMedCentralCrossRef

21.

Puderbach M, Risse F, Biederer J, Ley-Zaporozhan J, Ley S, Szabo G, Semmler W, Kauczor H-U (2008) In vivo Gd-DTPA concentration for MR lung perfusion measurements: assessment with computed tomography in a porcine model. Eur Radiol 18:2102–2107PubMedCrossRef

22.

Risse F, Eichinger M, Kauczor H-U, Semmler W, Puderbach M (2011) Improved visualization of delayed perfusion in lung MRI. Eur J Radiol 77:105–110PubMedCrossRef

23.

Kuder TA, Risse F, Eichinger M, Ley S, Puderbach M, Kauczor H-U, Fink C (2008) New method for 3D parametric visualization of contrast-enhanced pulmonary perfusion MRI data. Eur Radiol 18:291–297PubMedCrossRef

24.

Bhalla M, Turcios N, Aponte V, Jenkins M, Leitman BS, McCauley DI, Naidich DP (1991) Cystic fibrosis: scoring system with thin-section CT. Radiology 179:783–788PubMedCrossRef

25.

Helbich TH, Heinz-Peer G, Eichler I, Wunderbaldinger P, Götz M, Wojnarowski C, Brasch RC, Herold CJ (1999) Cystic fibrosis: CT assessment of lung involvement in children and adults. Radiology 213:537–544PubMedCrossRef

26.

Brody AS, Kosorok MR, Li Z, Broderick LS, Foster JL, Laxova A, Bandla H, Farrell PM (2006) Reproducibility of a scoring system for computed tomography scanning in cystic fibrosis. J Thorac Imaging 21:14–21PubMedCrossRef

27.

Eichinger M, Optazaite D-E, Kopp-Schneider A, Hintze C, Biederer J, Niemann A, Mall MA, Wielpütz MO, Kauczor H-U, Puderbach M (2011) Morphologic and functional scoring of cystic fibrosis lung disease using MRI. Eur J Radiol

28.

de Jong PA, Tiddens HAWM (2007) Cystic fibrosis specific computed tomography scoring. Proc Am Thorac Soc 4:338–342PubMedCrossRef

29.

Santamaria F, Grillo G, Guidi G, Rotondo A, Raia V, de Ritis G, Sarnelli P, Caterino M, Greco L (1998) Cystic fibrosis: when should high-resolution computed tomography of the chest be obtained? Pediatrics 101:908–913PubMedCrossRef

30.

Stein PD, Fowler SE, Goodman LR, Gottschalk A, Hales CA, Hull RD, Leeper KV, Popovich J, Quinn DA, Sos TA, Sostman HD, Tapson VF, Wakefield TW, Weg JG, Woodard PK (2006) Multidetector computed tomography for acute pulmonary embolism. N Engl J Med 354:2317–2327PubMedCrossRef

31.

Oudkerk M, van Beek EJR, Wielopolski P, van Ooijen PMA, Brouwers-Kuyper EMJ, Bongaerts AHH, Berghout A (2002) Comparison of contrast-enhanced magnetic resonance angiography and conventional pulmonary angiography for the diagnosis of pulmonary embolism: a prospective study. Lancet 359:1643–1647PubMedCrossRef

32.

Stein PD, Gottschalk A, Sostman HD, Chenevert TL, Fowler SE, Goodman LR, Hales CA, Hull RD, Kanal E, Leeper KV Jr, Nadich DP, Sak DJ, Tapson VF, Wakefield TW, Weg JG, Woodard PK (2008) Methods of Prospective Investigation of Pulmonary Embolism Diagnosis III (PIOPED III). Semin Nucl Med 38:462–470PubMedPubMedCentralCrossRef

33.

Kluge A, Luboldt W, Bachmann G (2006) Acute pulmonary embolism to the subsegmental level: diagnostic accuracy of three MRI techniques compared with 16-MDCT. AJR Am J Roentgenol 187:W7–W14PubMedCrossRef

34.

Kluge A, Gerriets T, Stolz E, Dill T, Mueller K-D, Mueller C, Bachmann G (2006) Pulmonary perfusion in acute pulmonary embolism: agreement of MRI and SPECT for lobar, segmental and subsegmental perfusion defects. Acta Radiol 47:933–940PubMedCrossRef

35.

Kluge A, Gerriets T, Müller C, Ekinci O, Neumann T, Dill T, Bachmann G (2005) Thoracic real-time MRI: experience from 2200 examinations in acute and ill-defined thoracic diseases. Rofo 177:1513–1521PubMedCrossRef

36.

Hintze C, Biederer J, Wenz HW, Eberhardt R, Kauczor HU (2006) MRI in staging of lung cancer. Radiologe 46(251–4):256–259

37.

Yi CA, Shin KM, Lee KS, Kim B-T, Kim H, Kwon OJ, Choi JY, Chung MJ (2008) Non-small cell lung cancer staging: efficacy comparison of integrated PET/CT versus 3.0-T whole-body MR imaging. Radiology 248:632–642PubMedCrossRef

38.

Ohba Y, Nomori H, Mori T, Ikeda K, Shibata H, Kobayashi H, Shiraishi S, Katahira K (2009) Is diffusion-weighted magnetic resonance imaging superior to positron emission tomography with fludeoxyglucose F 18 in imaging non-small cell lung cancer? J Thorac Cardiovasc Surg 138:439–445PubMedCrossRef

39.

Mori T, Nomori H, Ikeda K, Kawanaka K, Shiraishi S, Katahira K, Yamashita Y (2008) Diffusion-weighted magnetic resonance imaging for diagnosing malignant pulmonary nodules/masses: comparison with positron emission tomography. J Thorac Oncol 3:358–364PubMedCrossRef

40.

Qi LP, Zhang XP, Tang L, Li J, Sun YS, Zhu GY (2009) Using diffusion-weighted MR imaging for tumor detection in the collapsed lung: a preliminary study. Eur Radiol 19:333–341PubMedCrossRef

41.

Akata S, Kajiwara N, Park J, Yoshimura M, Kakizaki D, Abe K, Hirano T, Ohira T, Tsuboi M, Kato H (2008) Evaluation of chest wall invasion by lung cancer using respiratory dynamic MRI. J Med Imaging Radiat Oncol 52:36–39PubMedCrossRef

42.

Ohno Y, Koyama H, Takenaka D, Nogami M, Maniwa Y, Nishimura Y, Ohbayashi C, Sugimura K (2008) Dynamic MRI, dynamic multidetector-row computed tomography (MDCT), and coregistered 2-[fluorine-18]-fluoro-2-deoxy-D-glucose-positron emission tomography (FDG-PET)/CT: comparative study of capability for management of pulmonary nodules. J Magn Reson Imaging 27:1284–1295PubMedCrossRef

43.

Pauls S, Mottaghy FM, Schmidt SA, Krüger S, Möller P, Brambs H-J, Wunderlich A (2008) Evaluation of lung tumor perfusion by dynamic contrast-enhanced MRI. Magn Reson Imaging 26:1334–1341PubMedCrossRef

44.

Hebestreit A, Schultz G, Trusen A, Hebestreit H (2004) Follow-up of acute pulmonary complications in cystic fibrosis by magnetic resonance imaging: a pilot study. Acta Paediatr 93:414–416PubMedCrossRef

45.

Cohen MD, Eigen H, Scott PH, Tepper R, Cory DA, Smith JA, Scales RL (1986) Magnetic resonance imaging of inflammatory lung disorders: preliminary studies in children. Pediatr Pulmonol 2:211–217PubMedCrossRef

46.

Abolmaali ND, Schmitt J, Krauss S, Bretz F, Deimling M, Jacobi V, Vogl TJ (2004) MR imaging of lung parenchyma at 0.2T: evaluation of imaging techniques, comparative study with chest radiography and interobserver analysis. Eur Radiol 14:703–708PubMedCrossRef

47.

Wagner M, Böwing B, Kuth R, Deimling M, Rascher W, Rupprecht T (2001) Low field thoracic MRI–a fast and radiation free routine imaging modality in children. Magn Reson Imaging 19:975–983PubMedCrossRef

48.

Peltola V, Ruuskanen O, Svedström E (2008) Magnetic resonance imaging of lung infections in children. Pediatr Radiol 38:1225–1231PubMedCrossRef

49.

Hirsch W, Sorge I, Krohmer S, Weber D, Meier K, Till H (2008) MRI of the lungs in children. Eur J Radiol 68:278–288PubMedCrossRef

50.

Yi CA, Lee KS, Han J, Chung MP, Chung MJ, Shin KM (2008) 3-T MRI for differentiating inflammation- and fibrosis-predominant lesions of usual and nonspecific interstitial pneumonia: comparison study with pathologic correlation. AJR Am J Roentgenol 190:878–885PubMedCrossRef

51.

Montella S, Santamaria F, Salvatore M, Pignata C, Maglione M, Iacotucci P, Mollica C (2009) Assessment of chest high-field magnetic resonance imaging in children and young adults with noncystic fibrosis chronic lung disease: comparison to high-resolution computed tomography and correlation with pulmonary function. Invest Radiol 44:532–538PubMedCrossRef

52.

Mannino DM, Doherty DE, Sonia Buist A (2006) Global Initiative on Obstructive Lung Disease (GOLD) classification of lung disease and mortality: findings from the Atherosclerosis Risk in Communities (ARIC) study. Respir Med 100:115–122PubMedCrossRef

53.

Bankier AA, O’Donnell CR, Mai VM, Storey P, De Maertelaer V, Edelman RR, Chen Q (2004) Impact of lung volume on MR signal intensity changes of the lung parenchyma. J Magn Reson Imaging 20:961–966PubMedCrossRef

54.

Ley-Zaporozhan J, Ley S, Kauczor H-U (2008) Morphological and functional imaging in COPD with CT and MRI: present and future. Eur Radiol 18:510–521PubMedCrossRef

55.

Decramer M, Gosselink R, Troosters T, Verschueren M, Evers G (1997) Muscle weakness is related to utilization of health care resources in COPD patients. Eur Respir J 10:417–423PubMedCrossRef

56.

Henderson AC, Ingenito EP, Salcedo ES, Moy ML, Reilly JJ, Lutchen KR (2007) Dynamic lung mechanics in late-stage emphysema before and after lung volume reduction surgery. Respir Physiol Neurobiol 155:234–242PubMedCrossRef

57.

Suga K, Tsukuda T, Awaya H, Takano K, Koike S, Matsunaga N, Sugi K, Esato K (1999) Impaired respiratory mechanics in pulmonary emphysema: evaluation with dynamic breathing MRI. J Magn Reson Imaging 10:510–520PubMedCrossRef

58.

Iwasawa T, Yoshiike Y, Saito K, Kagei S, Gotoh T, Matsubara S (2000) Paradoxical motion of the hemidiaphragm in patients with emphysema. J Thorac Imaging 15:191–195PubMedCrossRef

59.

Iwasawa T, Kagei S, Gotoh T, Yoshiike Y, Matsushita K, Kurihara H, Saito K, Matsubara S (2002) Magnetic resonance analysis of abnormal diaphragmatic motion in patients with emphysema. Eur Respir J 19:225–231PubMedCrossRef

60.

Iwasawa T, Takahashi H, Ogura T, Asakura A, Gotoh T, Kagei S, J-ichi N, Obara M, Inoue T (2007) Correlation of lung parenchymal MR signal intensity with pulmonary function tests and quantitative computed tomography (CT) evaluation: a pilot study. J Magn Reson Imaging 26:1530–1536PubMedCrossRef

61.

Hogg JC, Chu F, Utokaparch S, Woods R, Elliott WM, Buzatu L, Cherniack RM, Rogers RM, Sciurba FC, Coxson HO, Pare DP (2004) The nature of small-airway obstruction in chronic obstructive pulmonary disease. N Engl J Med 350:2645–2653PubMedCrossRef

62.

Heussel CP, Ley S, Biedermann A, Rist A, Gast KK, Schreiber WG, Kauczor H-U (2004) Respiratory lumenal change of the pharynx and trachea in normal subjects and COPD patients: assessment by cine-MRI. Eur Radiol 14:2188–2197PubMedCrossRef

63.

Euler US, Liljestrand G (1946) Observations on the pulmonary arterial blood pressure in the cat. Acta Physiol Scand 12:301–320CrossRef

64.

Theissen IL, Meissner A (1996) Hypoxic pulmonary vasoconstriction. Anaesthesist 45:643–652PubMedCrossRef

65.

Morrison NJ, Abboud RT, Müller NL, Miller RR, Gibson NN, Nelems B, Evans KG (1990) Pulmonary capillary blood volume in emphysema. Am Rev Respir Dis 141:53–61PubMedCrossRef

66.

Cederlund K, Högberg S, Jorfeldt L, Larsen F, Norman M, Rasmussen E, Tylén U (2003) Lung perfusion scintigraphy prior to lung volume reduction surgery. Acta Radiol 44:246–251PubMedCrossRef

67.

Sandek K, Bratel T, Lagerstrand L, Rosell H (2002) Relationship between lung function, ventilation-perfusion inequality and extent of emphysema as assessed by high-resolution computed tomography. Respir Med 96:934–943PubMedCrossRef

68.

Ley-Zaporozhan J, Ley S, Eberhardt R, Weinheimer O, Fink C, Puderbach M, Eichinger M, Herth F, Kauczor H-U (2007) Assessment of the relationship between lung parenchymal destruction and impaired pulmonary perfusion on a lobar level in patients with emphysema. Eur J Radiol 63:76–83PubMedCrossRef

69.

Sergiacomi G, Sodani G, Fabiano S, Manenti G, Spinelli A, Konda D, Di Roma M, Schillaci O, Simonetti G (2003) MRI lung perfusion 2D dynamic breath-hold technique in patients with severe emphysema. In Vivo 17:319–324PubMed

70.

Fink C, Puderbach M, Bock M, Lodemann K-P, Zuna I, Schmähl A, Delorme S, Kauczor H-U (2004) Regional lung perfusion: assessment with partially parallel three-dimensional MR imaging. Radiology 231:175–184PubMedCrossRef

71.

Ohno Y, Koyama H, Nogami M, Takenaka D, Matsumoto S, Yoshimura M, Kotani Y, Sugimura K (2007) Postoperative lung function in lung cancer patients: comparative analysis of predictive capability of MRI, CT, and SPECT. AJR Am J Roentgenol 189:400–408PubMedCrossRef

72.

Molinari F, Fink C, Risse F, Tuengerthal S, Bonomo L, Kauczor H-U (2006) Assessment of differential pulmonary blood flow using perfusion magnetic resonance imaging: comparison with radionuclide perfusion scintigraphy. Invest Radiol 41:624–630PubMedCrossRef

73.

Amundsen T, Torheim G, Kvistad KA, Waage A, Bjermer L, Nordlid KK, Johnsen H, Asberg A, Haraldseth O (2002) Perfusion abnormalities in pulmonary embolism studied with perfusion MRI and ventilation-perfusion scintigraphy: an intra-modality and inter-modality agreement study. J Magn Reson Imaging 15:386–394PubMedCrossRef

74.

Alford SK, van Beek EJR, McLennan G, Hoffman EA (2010) Heterogeneity of pulmonary perfusion as a mechanistic image-based phenotype in emphysema susceptible smokers. Proc Natl Acad Sci USA 107:7485–7490PubMedPubMedCentralCrossRef

75.

Ohno Y, Higashino T, Takenaka D, Sugimoto K, Yoshikawa T, Kawai H, Fujii M, Hatabu H, Sugimura K (2004) MR angiography with sensitivity encoding (SENSE) for suspected pulmonary embolism: comparison with MDCT and ventilation-perfusion scintigraphy. AJR Am J Roentgenol 183:91–98PubMedCrossRef

76.

Ohno Y, Hatabu H, Murase K, Higashino T, Kawamitsu H, Watanabe H, Takenaka D, Fujii M, Sugimura K (2004) Quantitative assessment of regional pulmonary perfusion in the entire lung using three-dimensional ultrafast dynamic contrast-enhanced magnetic resonance imaging: preliminary experience in 40 subjects. J Magn Reson Imaging 20:353–365PubMedCrossRef

77.

Müller NL, Mayo JR, Zwirewich CV (1992) Value of MR imaging in the evaluation of chronic infiltrative lung diseases: comparison with CT. AJR Am J Roentgenol 158:1205–1209PubMedCrossRef

78.

Rieger C, Herzog P, Eibel R, Fiegl M, Ostermann H (2008) Pulmonary MRI–a new approach for the evaluation of febrile neutropenic patients with malignancies. Support Care Cancer 16:599–606PubMedCrossRef

79.

Lutterbey G, Gieseke J, von Falkenhausen M, Morakkabati N, Schild H (2005) Lung MRI at 3.0T: a comparison of helical CT and high-field MRI in the detection of diffuse lung disease. Eur Radiol 15:324–328PubMedCrossRef

80.

Lutterbey G, Grohé C, Gieseke J, von Falkenhausen M, Morakkabati N, Wattjes MP, Manka R, Trog D, Schild HH (2007) Initial experience with lung-MRI at 3.0T: comparison with CT and clinical data in the evaluation of interstitial lung disease activity. Eur J Radiol 61:256–261PubMedCrossRef

81.

McFadden RG, Carr TJ, Wood TE (1987) Proton magnetic resonance imaging to stage activity of interstitial lung disease. Chest 92:31–39PubMedCrossRef

82.

Berthezène Y, Vexler V, Kuwatsuru R, Rosenau W, Mühler A, Clément O, Price DC, Brasch RC (1992) Differentiation of alveolitis and pulmonary fibrosis with a macromolecular MR imaging contrast agent. Radiology 185:97–103PubMedCrossRef

83.

Gaeta M, Blandino A, Scribano E, Minutoli F, Barone M, Andò F, Pandolfo I (2000) Chronic infiltrative lung diseases: value of gadolinium-enhanced MRI in the evaluation of disease activity–early report. Chest 117:1173–1178PubMedCrossRef

84.

Jacob RE, Amidan BG, Soelberg J, Minard KR (2010) In vivo MRI of altered proton signal intensity and T2 relaxation in a bleomycin model of pulmonary inflammation and fibrosis. J Magn Reson Imaging 31:1091–1099PubMedCrossRef

85.

Weick S, Oechsner M, Blaimer M, Breuer H, Köstler H, Hahn D (2009) Self -gated 3D FLASH imaging of the human lung under free breathing using DC signals. Proceedings 17th Scientific Meeting, ISMRM

86.

Song HK, Dougherty L (2000) k-space weighted image contrast (KWIC) for contrast manipulation in projection reconstruction MRI. Magn Reson Med 44:825–832PubMedCrossRef

87.

Song HK, Dougherty L (2004) Dynamic MRI with projection reconstruction and KWIC processing for simultaneous high spatial and temporal resolution. Magn Reson Med 52:815–824PubMedCrossRef

88.

Lin W, Guo J, Rosen MA, Song HK (2008) Respiratory motion-compensated radial dynamic contrast-enhanced (DCE)-MRI of chest and abdominal lesions. Magn Reson Med 60:1135–1146PubMedPubMedCentralCrossRef

89.

Bauman G, Puderbach M, Deimling M, Jellus V, Chefd’hotel C, Dinkel J, Hintze C, Kauczor H-U, Schad LR (2009) Non-contrast-enhanced perfusion and ventilation assessment of the human lung by means of fourier decomposition in proton MRI. Magn Reson Med 62:656–664PubMedCrossRef

90.

Chefd’hotel C, Hermosillo G, Faugeras O (2002) Flows of Diffeomorphisms for Multimodal Image Registration. Proceedings of the IEEE International Symposium on Biomedical Imaging (ISBI’2002), Piscataway, NJ, USA: Institute of Electrical and Electronics Engineers:753–756

91.

Suga K, Ogasawara N, Okada M, Tsukuda T, Matsunaga N, Miyazaki M (2002) Lung perfusion impairments in pulmonary embolic and airway obstruction with noncontrast MR imaging. J Appl Physiol 92:2439–2451PubMedCrossRef

92.

Bauman G, Lützen U, Ullrich M, Gaass T, Dinkel J, Elke G, Meybohm P, Frerichs I, Hoffmann B, Borggrefe J, Knuth HC, Schupp J, Prüm H, Eichinger M, Pudebach M, Biederer J, Hintze C (2011) Pulmonary functional imaging: qualitative comparison of Fourier decomposition MR imaging with SPECT/CT in porcine lung. Radiology 260:551–559PubMedCrossRef

93.

Pichler BJ, Judenhofer M, Pfannenberg C (2008) Multimodal imaging approaches: PET/CT and PET/MRI. In: Handb Exp Pharmacol:109–132

94.

Shao Y, Cherry SR, Farahani K, Meadors K, Siegel S, Silverman RW, Marsden PK (1997) Simultaneous PET and MR imaging. Phys Med Biol 42:1965–1970PubMedCrossRef

95.

Pichler BJ, Kolb A, Nägele T, Schlemmer H-P (2010) PET/MRI: paving the way for the next generation of clinical multimodality imaging applications. J Nucl Med 51:333–336PubMedCrossRef

96.

Zaidi H, Ojha N, Morich M, Griesmer J, Hu Z, Maniawski P, Ratib O, Izquierdo-Garcia D, Fayad ZA, Shao L (2011) Design and performance evaluation of a whole-body Ingenuity TF PET-MRI system. Phys Med Biol 56:3091–3106PubMedPubMedCentralCrossRef

97.

Pichler BJ, Judenhofer MS, Wehrl HF (2008) PET/MRI hybrid imaging: devices and initial results. Eur Radiol 18:1077–1086PubMedCrossRef

98.

Wehrl HF, Judenhofer MS, Wiehr S, Pichler BJ (2009) Pre-clinical PET/MR: technological advances and new perspectives in biomedical research. Eur J Nucl Med Mol Imaging 36(Suppl 1):S56–S68PubMedCrossRef

99.

Ratib O, Beyer T (2011) Whole-body hybrid PET/MRI: ready for clinical use? Eur J Nucl Med Mol Imaging 38:992–995PubMedCrossRef

100.

Antoch G, Bockisch A (2009) Combined PET/MRI: a new dimension in whole-body oncology imaging? Eur J Nucl Med Mol Imaging 36(Suppl 1):S113–S120PubMedCrossRef

101.

Antoch G, Vogt FM, Freudenberg LS, Nazaradeh F, Goehde SC, Barkhausen J, Dahmen G, Bockisch A, Debatin JF, Ruehm SG (2003) Whole-body dual-modality PET/CT and whole-body MRI for tumor staging in oncology. JAMA 290:3199–3206PubMedCrossRef

Title: MRI of the lung (3/3)—current applications and future perspectives
Authors: Jürgen Biederer
S. Mirsadraee
M. Beer
F. Molinari
C. Hintze
G. Bauman
M. Both
E. J. R. Van Beek
J. Wild
M. Puderbach
Publication date: 01-08-2012
Publisher: Springer Berlin Heidelberg
Published in: Insights into Imaging / Issue 4/2012
Electronic ISSN: 1869-4101
DOI: https://doi.org/10.1007/s13244-011-0142-z

Keynote webinar | Spotlight on medication adherence

Springer Medicine

MRI of the lung (3/3)—current applications and future perspectives

Abstract

Background

Methods

Results

Conclusion

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Background

Methods

Results

Conclusion

Please log in to get access to this content

Other articles of this Issue 4/2012

A pictorial review of traumatic pericardial injuries

Stereology: a novel technique for rapid assessment of liver volume

MRI of the lung (1/3): methods

MRI of the lung (2/3). Why … when … how?

Process mapping of PTA and stent placement in a university hospital interventional radiology department

Multi-detector CT angiographic imaging in the follow-up of patients after endovascular abdominal aortic aneurysm repair (EVAR)